Jump to main content

博士論文

Efficacy of cabazitaxel and androgen splicing variant‑7 status in circulating tumor cells in Asian patients with metastatic castration‑resistant prostate cancer

Icons representing 博士論文
The cover of this title could differ from library to library.

Available in National Diet Library

Find on the publisher's website

NDL Digital Collections

Digital data available

Check on the publisher's website

Efficacy of cabazitaxel and androgen splicing variant‑7 status in circulating tumor cells in Asian patients with metastatic castration‑resistant prostate cancer

Persistent ID (NDL)
info:ndljp/pid/12770167
Material type
博士論文
Author
芦澤, 健
Publisher
-
Date granted
2023-01-20
Material Format
Digital
Capacity, size, etc.
-
Degree grantor and degree
順天堂大学,博士（医学）
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii ResearchLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General)：

2022年度

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Table of Contents

Provided by：国立国会図書館デジタルコレクション

  • 2024-12-06 再収集

  • 2024-12-06 再収集

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
Efficacy of cabazitaxel and androgen splicing variant‑7 status in circulating tumor cells in Asian patients with metastatic castration‑resistant prostate cancer
Author/Editor
芦澤, 健
Author Heading
芦澤, 健
Publication Date
2023-01-20
Publication Date (W3CDTF)
2023-01-20
Alternative Title
(去勢抵抗性前立腺癌(mCRPC)に対する血中循環腫瘍細胞測定を用いた血中腫瘍循環細胞,アンドロゲン受容体スプライスバリアント-7とカバジタキセルの有効性の検討)
Degree Grantor
順天堂大学
Date Granted
2023-01-20
Date Granted (W3CDTF)
2023-01-20